, Tracking Stock Market Picks
Enter Symbol:
C.r. Bard, Inc. (BCR) [hlAlert]

up 122.32 %

C.r. Bard, Inc. (BCR) rated Overweight with price target $110 by Lehman Brothers

Posted on: Friday,  Jun 20, 2008  10:25 AM ET by Lehman Brothers

Lehman Brothers rated Overweight C.r. Bard, Inc. (NYSE: BCR) on 06/20/2008, when the stock price was $88.38. Since
then, C.r. Bard, Inc. has gained 122.32% as of 01/20/2016's recent price of $196.49.
If you would have followed this Lehman Brothers's recommendation on BCR, you would have gained 122.32% of your investment in 2770 days.

C.R. Bard, Inc. is one of the worldwide leaders in developing, manufacturing, and supplying healthcare products that focus on Vascular, Urology, and Oncology Disease States. In addition, Bard offers a complete line of advanced Surgical Specialty products and services that address needs in hernia repair, performance irrigation, hemostasis, and other areas.

Lehman Brothers Holdings Inc. has filed for bankruptcy protection in the U.S.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/20/2008 10:25 AM Buy
88.38 110.00
as of 12/24/2008
1 Week down  -11.11 %
1 Month down  -8.34 %
3 Months down  -17.00 %
1 YTD down  -19.43 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy